bioMérieux SA is a French multinational
biotechnology
Biotechnology is the integration of natural sciences and engineering sciences in order to achieve the application of organisms, cells, parts thereof and molecular analogues for products and services. The term ''biotechnology'' was first used ...
company founded and headquartered in
Marcy-l'Étoile,
France
France (), officially the French Republic ( ), is a country primarily located in Western Europe. It also comprises of Overseas France, overseas regions and territories in the Americas and the Atlantic Ocean, Atlantic, Pacific Ocean, Pac ...
, close to
Lyon
Lyon,, ; Occitan: ''Lion'', hist. ''Lionés'' also spelled in English as Lyons, is the third-largest city and second-largest metropolitan area of France. It is located at the confluence of the rivers Rhône and Saône, to the northwest of ...
. bioMérieux is present in 44 countries and serves more than 160 countries through a large network of distributors.
bioMérieux provides diagnostic solutions (reagents, instruments, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases,
cancer
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread. Possible signs and symptoms include a lump, abnormal b ...
screening, and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
bioMérieux is listed on the
NYSE Euronext Paris stock exchange
A stock exchange, securities exchange, or bourse is an exchange where stockbrokers and traders can buy and sell securities, such as shares of stock, bonds and other financial instruments. Stock exchanges may also provide facilities for t ...
(BIM – ISIN: FR0013280286).
Revenue
bioMérieux had revenues of €3.1 billion as of 2020 with 93% of sales occurring outside France.
History
In 1897, Marcel Mérieux, former assistant to
Louis Pasteur
Louis Pasteur (, ; 27 December 1822 – 28 September 1895) was a French chemist and microbiologist renowned for his discoveries of the principles of vaccination, microbial fermentation and pasteurization, the latter of which was named afte ...
, founded the
Mérieux Biological Institute, which later became
Institut Mérieux
Institut Mérieux is a French holding company owned by the Mérieux family from Lyon.
History
It was created by Marcel Mérieux in 1897 under the name ''Institut Biologique Mérieux'' (Mérieux Biological Institute). The vaccine development b ...
. In 1963, Alain Mérieux founded BD Mérieux, of which he became majority shareholder in 1974. BD Mérieux would later become bioMérieux. The company expanded its services and offerings through product development, acquisitions and partnerships:
* Api Systems, acquired in 1987
* Vitek Systems, acquired in 1988
[
* Organon Teknika, acquired in 2001 from Akzo Nobel
* Bacterial Barcodes, acquired in 2006
* Biomedics (Spain) and BTF (Australia), acquired in 2007
* AB Biodisk (Sweden), AviaraDx (bioTheragnostics today) (USA) and PML Microbiologicals (USA), acquired in 2008
* Meikang Biotech and of Shanghai Zenka Biotechnology, acquired in 2010
* AES Laboratoire and Argene (France), acquired in 2011
* RAS (India), a specialist in molecular biology, acquired in 2012
*Partnership with Quanterix in 2012 for the development of a new generation of ultrasensitive, multiplex immunoassays.
* BioFire Diagnostics Inc., a privately held US-based company specialized in molecular biology, acquired in 2014
* BioMerieux molecular biology affiliate BioFire, LLC. opened the Alain Mérieux Center for Molecular Diagnostics in Salt Lake City, Utah in 2017
* Invisible Sentinel, A Philadelphia life sciences company that develops novel technology to quickly detect pathogens in food and beverages including wine and beer.
]Institut Mérieux
Institut Mérieux is a French holding company owned by the Mérieux family from Lyon.
History
It was created by Marcel Mérieux in 1897 under the name ''Institut Biologique Mérieux'' (Mérieux Biological Institute). The vaccine development b ...
, which belongs to the Mérieux family, is the main shareholder of bioMérieux. Jean-Luc Belingard is President, and Alexandre Mérieux is General Director.United States Department of Defense
The United States Department of Defense (DoD, USDOD or DOD) is an executive branch department of the federal government charged with coordinating and supervising all agencies and functions of the government directly related to national sec ...
. Lastly, bioMérieux launched development on an expanded version of its BioFire FilmArray Respiratory Panel 2. The new version included SARS-CoV-2 in addition to the 21 other common respiratory pathogens and delivered results in approximately 45 minutes. After this announcement, Labrador issued a statement claiming that when it filed the lawsuit against BioFire it had no idea BioFire was developing COVID-19 testing kits.SARS-CoV-2 variants
There are many variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19). Some are believed, or have been stated, to be of particular importance due to their potential ...
. The application identifies variants based on international nomenclatures, including any new variant of concern (VOC), and is compatible with three major sequencing platforms ( Illumina, Oxford Nanopore, Thermo Fisher).
Shareholders
As of February 2021:
References
External links
Corporate WebsiteInvestor websitebioMerieux USA WebsiteBloomberg Snapshot
{{DEFAULTSORT:Biomerieux
Biotechnology companies of France
French brands
Companies listed on Euronext Paris
HIV/AIDS in Iran
Biotechnology companies established in 1963
French companies established in 1963
CAC Next 20